SARS-CoV-2 spike protein antibody titers 6 months after SARS-CoV-2 mRNA vaccination among patients undergoing hemodialysis in Japan
2022.06.28
For inquiries regarding this article
Daisuke Kanai
Department of Medical Science and Cardiorenal Medicine, Graduate School of Medicine, Yokohama City University
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan
Department of Medical Science and Cardiorenal Medicine, Graduate School of Medicine, Yokohama City University
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan
Hiromichi Wakui
Associate Professor
Department of Medical Science and Cardiorenal Medicine, Graduate School of Medicine, Yokohama City University
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan
Associate Professor
Department of Medical Science and Cardiorenal Medicine, Graduate School of Medicine, Yokohama City University
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan
Kouichi Tamura
Professor
Department of Medical Science and Cardiorenal Medicine, Graduate School of Medicine, Yokohama City University
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan
Professor
Department of Medical Science and Cardiorenal Medicine, Graduate School of Medicine, Yokohama City University
3-9 Fukuura, Kanazawa-ku, Yokohama, Kanagawa, 236-0004, Japan
